JNJ

The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024

By Muslim Farooque, InvestorPlace Contributor
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements

Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot

By Chandler Capital, InvestorPlace Contributor
Healthcare stocks to buy are not talked about as much right now, but are great stocks investors should consider adding.

Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year

By Vandita Jadeja
Investing in the stock market isn’t without the risks, but what if you could generate extra income from your investment? If you are a risk-averse…

7 Dividend Stocks to Buy and Never Sell: January 2024 Edition

By Rich Duprey, InvestorPlace Contributor
Seeking out dividend stocks to buy and hold is a time-tested strategy that has proved itself in all types of markets.

7 Must-Have Stocks for Serious Wealth Accumulation

By Yiannis Zourmpanos, InvestorPlace Contributor
Certain stocks stand out as stalwarts in finance and commerce, charting a course toward serious wealth accumulation.

7 Mighty Healthcare Stocks Changing the Game of Medicine

By Josh Enomoto, InvestorPlace Contributor
With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily,…

The 3 Most Undervalued Value Stocks to Buy in January

By Josh Enomoto, InvestorPlace Contributor
With Wall Street jubilant about avoiding a recession last year, investors may want to continue betting on the same horse, although here’s the thing: targeting…

Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation

By Yiannis Zourmpanos, InvestorPlace Contributor
For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the "Dividend Dynasty."

Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?

By Josh Enomoto, InvestorPlace Contributor
With Johnson & Johnson buying out Ambrx Biopharma, the win-win deal boosted AMAM stock while better positioning J&J’s oncology unit.

Dow Darlings: Top 3 Stocks That Will Lead the Charge in 2024

By Matthew Farley, InvestorPlace Contributor
These Dow stocks will perform better than others this year and take the leaderboard for strong gains and security.

2024’s Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns

By Matthew Farley, InvestorPlace Contributor
Some blue-chip stocks are poised to outperform others this year, so consider adding these to your portfolio.

Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires

By Vandita Jadeja
If you believe in long-term investing like me, you will look for stocks that have a strong performance history and an ability to thrive in…

Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times

By Vandita Jadeja
Enjoy steady passive income and capital growth in your portfolio through these three dividend stocks with steady payouts.

Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness

By Muslim Farooque, InvestorPlace Contributor
Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.

7 Rock-Solid Dividend Stocks to Trust in Difficult Times

By Josh Enomoto, InvestorPlace Contributor
While the upcoming new year generally brings optimistic sentiment to the market, investors should be prepared for anything, which is why solid dividend stocks represent…

Build Your Future Portfolio: 3 Generous Dividend Stocks

By Vandita Jadeja
Enjoy passive income and capital appreciation in 2024 with these three dividend stocks to buy before the end of this year.

7 Stocks That Might Win on Election Year Uncertainty

By Josh Enomoto, InvestorPlace Contributor
Soon, it will be that favorite time of the quadrennial cycle where American citizens will decide the future of this great nation, subsequently necessitating a…

3 of the Most Attractive Dividend Stocks in the Pharma Space

By Muslim Farooque, InvestorPlace Contributor
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.

The Dogs of the Dow May Pay Big Dividends in 2024

By Paul R. La Monica, InvestorPlace Contributor
The dogs of the Dow could be great buys in 2024 for investors looking to take a chance on some underdogs that pay dividends too.
Load More